SRT-100 is an Optimal Therapy Modality for Non-Melanoma Skin Cancers

0 Views
administrator
administrator
07/10/23

Featuring our SharpBeam precision superficial radiotherapy, the SRT-100 is an excellent treatment option for patients with non-Melanoma (NMSC) skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Ask your doctor about SRT-100 when you weigh your treatment options!

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next